IRIS UniCatt

Fagotti, Anna
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.556
AS - Asia 13.680
EU - Europa 11.404
SA - Sud America 2.760
AF - Africa 375
OC - Oceania 43
Continente sconosciuto - Info sul continente non disponibili 17
Totale 42.835
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.093
SG - Singapore 6.818
CN - Cina 2.678
DE - Germania 2.590
BR - Brasile 2.263
IT - Italia 1.870
SE - Svezia 1.758
VN - Vietnam 1.278
FR - Francia 1.035
NL - Olanda 819
IN - India 726
IE - Irlanda 623
UA - Ucraina 537
GB - Regno Unito 513
PL - Polonia 475
ID - Indonesia 420
FI - Finlandia 377
JP - Giappone 349
HK - Hong Kong 347
RU - Federazione Russa 288
CA - Canada 186
AR - Argentina 185
BD - Bangladesh 166
MX - Messico 162
TR - Turchia 147
IQ - Iraq 144
ZA - Sudafrica 99
KR - Corea 97
ES - Italia 88
AT - Austria 77
EC - Ecuador 77
BE - Belgio 75
PK - Pakistan 60
SA - Arabia Saudita 56
CI - Costa d'Avorio 52
CZ - Repubblica Ceca 52
PH - Filippine 51
CO - Colombia 50
MA - Marocco 48
KE - Kenya 44
VE - Venezuela 44
UZ - Uzbekistan 42
CL - Cile 41
IR - Iran 38
PY - Paraguay 35
CH - Svizzera 34
EG - Egitto 34
AU - Australia 29
JO - Giordania 27
LT - Lituania 26
PE - Perù 25
MY - Malesia 24
RO - Romania 24
IL - Israele 23
UY - Uruguay 22
AE - Emirati Arabi Uniti 21
OM - Oman 21
KZ - Kazakistan 20
TN - Tunisia 19
JM - Giamaica 18
AZ - Azerbaigian 17
HN - Honduras 16
DZ - Algeria 15
AL - Albania 14
HU - Ungheria 14
PA - Panama 14
PT - Portogallo 14
GR - Grecia 13
KG - Kirghizistan 13
TT - Trinidad e Tobago 13
ET - Etiopia 12
NP - Nepal 12
BG - Bulgaria 11
BO - Bolivia 11
BZ - Belize 11
DO - Repubblica Dominicana 11
HR - Croazia 11
LB - Libano 10
NZ - Nuova Zelanda 10
SN - Senegal 10
CR - Costa Rica 9
DK - Danimarca 9
EU - Europa 9
LV - Lettonia 9
NI - Nicaragua 8
RS - Serbia 8
TW - Taiwan 8
AM - Armenia 7
LK - Sri Lanka 7
MD - Moldavia 7
NG - Nigeria 7
PS - Palestinian Territory 7
SK - Slovacchia (Repubblica Slovacca) 7
AO - Angola 6
BH - Bahrain 6
MN - Mongolia 6
NO - Norvegia 6
LA - Repubblica Popolare Democratica del Laos 5
XK - ???statistics.table.value.countryCode.XK??? 5
GE - Georgia 4
Totale 42.732
Salva come PNG Salva come JPEG
Città #
Singapore 3.842
Chandler 2.054
San Jose 1.581
Ashburn 1.507
Amsterdam 745
Dublin 615
Beijing 600
Warsaw 420
Rome 416
New York 406
Ho Chi Minh City 402
San Mateo 401
Jakarta 377
Lauterbourg 364
Los Angeles 363
Frankfurt am Main 345
Hyderabad 333
Hanoi 330
Tokyo 321
Hong Kong 309
Jacksonville 298
Wilmington 288
Hefei 282
Boston 266
Ann Arbor 258
Milan 254
Nanjing 211
Dallas 210
Houston 195
Princeton 184
São Paulo 184
Moscow 181
Woodbridge 180
Helsinki 166
The Dalles 163
Fairfield 159
Marseille 159
Munich 159
Dearborn 147
Seattle 129
Cattolica 126
Santa Clara 124
Council Bluffs 106
Nürnberg 105
Buffalo 99
Redwood City 99
Chicago 98
Lawrence 97
Rio de Janeiro 91
Nuremberg 86
Orem 86
Seoul 86
Boardman 85
Kent 75
London 75
Da Nang 74
St Louis 72
Brussels 68
Nanchang 66
Paris 65
Atlanta 64
Brooklyn 62
Shanghai 62
Lappeenranta 61
Johannesburg 57
Haiphong 56
Bremen 55
Chennai 55
Düsseldorf 54
Hangzhou 54
Mountain View 54
Belo Horizonte 53
Abidjan 52
San Francisco 51
Izmir 50
Kunming 49
Toronto 49
Vienna 49
Baghdad 48
Brasília 48
Mexico City 48
Montreal 48
Denver 47
Phoenix 47
Guangzhou 46
Cambridge 44
Norwalk 44
Dhaka 43
Turku 43
Zhengzhou 43
Leawood 41
Nairobi 40
Tashkent 39
Augusta 38
Manchester 38
Stockholm 38
Poplar 37
Fuzhou 36
Salvador 36
Tianjin 36
Totale 23.502
Salva come PNG Salva come JPEG
Nome #
Clinical impact of SARS-CoV-2 infection among patients with vulvar cancer: the Gemelli Vul.Can multidisciplinary team 940
Clinical outcome of recurrent locally advanced cervical cancer (lacc) submitted to primary multimodality therapies 862
Elective Cancer Surgery in COVID-19-Free Surgical Pathways during the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study 530
Chemoradiation with concomitant boosts followed by radical surgery in locally advanced cervical cancer: long-term results of the ROMA-2 prospective phase 2 study 372
Laparoendoscopic Single-Site Surgery (LESS) for Treatment of Benign Adnexal Disease: Single-Center Experience Over 3-Years 347
Nutritional Interventions to Improve Clinical Outcomes in Ovarian Cancer: A Systematic Review of Randomized Controlled Trials. 299
A randomized study comparing the use of the Ligaclip with bipolar energy to prevent lymphocele during laparoscopic pelvic lymphadenectomy for gynecologic cancer. 288
Elderly and very elderly advanced ovarian cancer patients: Does the age influence the surgical management? 288
Long-term analysis of clinical outcome and complications in locally advanced cervical cancer patients administered concomitant chemoradiation followed by radical surgery 228
Laparoscopic staging of apparent early stage ovarian cancer: results of a large, retrospective, multi-institutional series 226
The impact of surgical delay on resectability of colorectal cancer: An international prospective cohort study 223
Total laparoscopic hysterectomy in early-stage endometrial cancer using an intrauterine manipulator: is it a bias for frozen section analysis? Case-control study 219
Upper abdominal surgery in advanced and recurrent ovarian cancer: role of diaphragmatic surgery 209
BRCA mutational status, initial disease presentation, and clinical outcome in high-grade serous advanced ovarian cancer: a multicenter study 209
Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: A systematic review and meta-analysis of individual patient data 206
Delaying surgery for patients with a previous SARS-CoV-2 infection 201
Chemoradiation with concomitant boosts followed by radical surgery in locally advanced cervical cancer: long-term results of the ROMA-2 prospective phase 2 study 196
The sonographic prediction of invasive carcinoma in unilocular-solid ovarian cysts in premenopausal patients: a pilot study. 193
Advanced vulvar carcinoma: is it worth operating? A perioperative management protocol for radical and reconstructive surgery 191
Neoadjuvant chemotherapy followed by conization in stage IB2–IIA1 cervical cancer larger than 2 cm: a pilot study 188
Secondary cytoreductive surgery in patients with isolated platinum-resistant recurrent ovarian cancer: A retrospective analysis 187
Laparoscopic, minilaparoscopic and single-port hysterectomy: perioperative outcomes 182
Urologic surgery in gynecologic oncology: a large single-institution experience 182
Laparoscopic surgical management of localized recurrent ovarian cancer: a single-institution experience. 181
Influence of Intraperitoneal Dissemination Assessed by Laparoscopy on Prognosis of Advanced Ovarian Cancer: An Exploratory Analysis of a Single-Institution Experience 178
Learning a new robotic surgical device: Telelap Alf X in gynaecological surgery 177
Should laparoscopy be included in the work-up of advanced ovarian cancer patients attempting interval debulking surgery? 176
Is frozen section analysis of pelvic lymph nodes accurate in locally advanced cervical cancer patients administered preoperative chemoradiation? 174
A laparoscopic risk-adjusted model to predict major complications after primary debulking surgery in ovarian cancer: A single-institution assessment 171
Phase III randomised clinical trial comparing primary surgery versus neoadjuvant chemotherapy in advanced epithelial ovarian cancer with high tumour load (SCORPION trial): Final analysis of peri-operative outcome. 169
Teaching and training in laparoscopic surgery: experience of Catholic Laparoscopy Advanced Surgery School in the basic gynecological surgery 166
Ultrasound evaluation of intra-abdominal sites of disease to predict the likelihood of suboptimal cytoreduction in advanced ovarian cancer: a propective study 165
Sexual and reproductive outcomes in early stage cervical cancer patients after excisional cone as a fertility-sparing surgery: An italian experience 164
Molecular profile of brca-negative long survivor high grade serous ovarian cancer patients using a somatic multigene panel 163
Excisional cone as fertility-sparing treatment in early-stage cervical cancer. 162
Fusion imaging in the preoperative assessment of the extension of disease in patients with advanced ovarian cancer: feasibility and agreement with laparoscopic findings 160
Hyperthermic intraperitoneal chemotherapy in interval debulking surgery for advanced epithelial ovarian cancer: A single-center, real-life experience 159
Rectosigmoid Mesorectal-Sparing Resection in Advanced Ovarian Cancer Surgery 158
Chemotherapy resistance in epithelial ovarian cancer: Mechanisms and emerging treatments 157
Impact of bevacizumab containing first line chemotherapy on recurrent disease in epithelial ovarian cancer: A case-control study 153
Oncologic and obstetric outcomes after simple conization for fertility-sparing surgery in FIGO 2018 stage IB1 cervical cancer 153
Laparoscopic surgical management of localized recurrent ovarian cancer: a single-institution experience 151
Minimally invasive versus standard laparotomic interval debulking surgery in ovarian neoplasm: A single-institution retrospective case-control study 150
Importance of a specialized pathologist for the examination of frozen sections of adnexal masses. 149
Secondary cytoreduction plus oxaliplatin-based HIPEC in platinum-sensitive recurrent ovarian cancer patients: a pilot study 149
Management of oligometastatic ovarian cancer recurrence during PARP inhibitor maintenance 146
Role of CT scan-based and clinical evaluation in the preoperative prediction of optimal cytoreduction in advanced ovarian cancer: a prospective trial 145
Building a personalized medicine infrastructure for gynecological oncology patients in a high-volume hospital 145
Laparoscopy vs. laparotomy for advanced ovarian cancer: a systematic review of the literature 144
Cytoreductive surgery plus HIPEC in platinum-sensitive recurrent ovarian cancer patients: A case-control study on survival in patients with two year follow-up 143
Learning curve and pitfalls of a laparoscopic score to describe peritoneal carcinosis in advanced ovarian cancer 139
Deep-Learning to Predict BRCA Mutation and Survival from Digital H&E Slides of Epithelial Ovarian Cancer 138
Prognostic Significance of Ultrasound Characteristics and Body Mass Index in Patients with Apparent Early-Stage Cervical Cancer: A Single-Center, Retrospective, Cohort Study 138
Single-Institution Propensity-Matched Study to Evaluate the Psychological Effect of Minimally Invasive Interval Debulking Surgery Versus Standard Laparotomic Treatment: From Body to Mind and Back 138
Cytoplasmic expression of oestrogen receptor beta (ERβ) as a prognostic factor in vulvar squamous cell carcinoma in elderly women. 138
Epithelial ovarian cancer and brain metastases: might the BRCA status, PARP inhibitor administration, and surgical treatment impact the survival? 137
The vulvar immunohistochemical panel (Vip) project: Molecular profiles of vulvar squamous cell carcinoma 137
Infiltrating T lymphocytes and programmed cell death protein-1/programmed death-ligand 1 expression in endometriosis-associated ovarian cancer 137
How to Select Early-Stage Cervical Cancer Patients Still Suitable for Laparoscopic Radical Hysterectomy: a Propensity-Matched Study 136
Arterial-enteric fistula after pelvic lymphadenectomy in secondary cytoreductive surgery for recurrent ovarian cancer 135
Feasibility of tumor testing for BRCA status in high-grade serous ovarian cancer using fresh-frozen tissue based approach 135
Prognostic factors value of germline and somatic brca in patients undergoing surgery for recurrent ovarian cancer with liver metastases 134
Beyond sentinel node algorithm. Toward a more tailored surgery for cervical cancer patients 134
Perioperative outcomes of laparoendoscopic single-site surgery (LESS) versus conventional laparoscopy for adnexal disease: a case--control study 133
Risk of postoperative pelvic abscess in major gynecologic oncology surgery: one-year single-institution experience 133
Telelap ALF-X vs Standard Laparoscopy for the Treatment of Early-Stage Endometrial Cancer: A Single-Institution Retrospective Cohort Study 133
Spliceogenic analysis of BRCA1 c.439T>C (rs794727800) variant by High Resolution Melting Analysis 133
Benefit from maintenance with PARP inhibitor in newly diagnosed ovarian cancer according to BRCA1/2 mutation type and site: a multicenter real-world study 132
Ultrasound and color power Doppler in the detection of metastatic omentum: a prospective study 131
Targeting the hallmarks of ovarian cancer: The big picture 131
Droplet digital PCR for large genomic rearrangements detection: A promising strategy in tissue BRCA1 testing 131
Validation of tumour-free distance as novel prognostic marker in early-stage cervical cancer: a retrospective, single-centre, cohort study 131
Douglas peritonectomy compared to recto-sigmoid resection in optimally cytoreduced advanced ovarian cancer patients: analysis of morbidity and oncological outcome 130
Surgical treatment of “large uterine masses” in pregnancy: A single-center experience 130
Laparoscopic Ovarian Transposition with Extraperitonealization of the Infundibulopelvic Ligament for Cervical Cancer in Ten Steps 130
Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study 129
The impact of surgical delay on resectability of colorectal cancer: An international prospective cohort study 129
Pathologic response to neoadjuvant chemotherapy in advanced ovarian cancer: utility of a scoring system to predict outcomes 129
Is there any therapeutic role of pelvic and para-aortic lymphadenectomy in apparent early stage epithelial ovarian cancer? 129
Neoadjuvant Chemotherapy in Pregnant Patients with Cervical Cancer: A Monocentric Retrospective Study 128
Hepatoceliac Lymph Node Involvement in Advanced Ovarian Cancer Patients: Prognostic Role and Clinical Considerations 128
Role of different approaches to the abdominal retroperitoneum for aortic lymphadenectomy in patients with gynecological cancers 127
Minimally invasive interval debulking surgery in ovarian neoplasm (MISSION trial-NCT02324595): A feasibility study 127
Prognostic role of metastasis tumor antigen 1 in patients with ovarian cancer: a clinical study 125
The role of liquid based cytology and ancillary techniques in the peritoneal washing analysis: Our institutional experience 125
Salvage lymphadenectomy in recurrent ovarian cancer patients: Analysis of clinical outcome and BRCA1/2 gene mutational status 125
BRCA testing delay during the COVID-19 pandemic: How to act? 125
Pd-l1 expression on circulating tumour-derived microvesicles as a complementary tool for stratification of high-grade serous ovarian cancer patients 125
Prognostic Factors for Surgical Failure in Malignant Bowel Obstruction and Peritoneal Carcinomatosis 125
BRCA testing on buccal swab to improve access to healthcare and cancer prevention: A performance evaluation 124
One-Step Nucleic Acid Amplification (OSNA): A fast molecular test based on CK19 mRNA concentration for assessment of lymph-nodes metastases in early stage endometrial cancer 124
Exploring the Control of PARP1 Levels in High-Grade Serous Ovarian Cancer 123
BRCA status and platinum sensitivity in advanced ovarian cancer according to Chemotherapy Response Score 123
A cost-effectiveness analysis of an integrated clinical-radiogenomic screening program for the identification of BRCA 1/2 carriers (e-PROBE study 123
Robotic Radical Hysterectomy After Concomitant Chemoradiation in Locally Advanced Cervical Cancer: A Prospective Phase II Study 123
Peritoneal Hpv-Dna Test In Cervical Cancer (Pioneer Study): A Proof Of Concept 123
Quality of life in patients with advanced ovarian cancer after primary debulking surgery versus neoadjuvant chemotherapy: Results from the randomised SCORPION trial (NCT01461850) 122
Resectability and Vascular Management of Retroperitoneal Gynecological Malignancies: A Large Single-institution Case-Series 122
Diet and Chemotherapy: The Effects of Fasting and Ketogenic Diet on Cancer Treatment 122
Tumor BRCA testing in ovarian cancer and EQA scheme: our experience of a critical evaluation 122
Totale 17.755
Salva come PNG Salva come JPEG
Categoria #
all - tutte 179.912
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 179.912
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021474 0 0 0 0 0 0 0 0 0 115 295 64
2021/20222.584 172 118 31 255 103 67 97 431 123 151 447 589
2022/20235.646 747 716 452 765 384 729 274 401 689 98 244 147
2023/20243.296 118 886 103 287 102 372 225 125 74 193 351 460
2024/20257.133 157 134 528 235 516 295 292 304 1.036 944 1.496 1.196
2025/202618.740 2.673 534 1.159 2.101 3.521 2.193 3.160 1.011 1.365 1.023 0 0
Totale 44.005